等待開盤 09-24 09:30:00 美东时间
+0.800
+1.96%
Viking Therapeutics (NASDAQ:VKTX) shares are surging after the company reported positive results for its weight-loss drug candidate — the stock gained over 40% in two days. • Vertex Pharmaceuticals stock is trading near recent highs. What’s next for VRTX stock? Vk2735 Holds Weight Loss with Less Fre...
今天 04:54
减肥药传来捷报!VKTX升近36%,给药频率减半仍维持97%减重;Vicor升逾19%,上调Q3营收指引;Grab Holdings升近9%,CEO增持近3000万美元股份>>
09-23 19:22
Viking Therapeutics Inc.(VKTX)收涨36%,创2024年2月份以来最佳单日表现。
09-23 04:04
Viking Therapeutics周二早盘股价大涨 31%。该公司公布旗下糖尿病及肥胖候选药物 VK2735 的最新研究主要终点阳性结果。用药 21 周...
09-23 00:04
纳指创出历史新高。 当地时间9月22日(周二),美国三大股指集体高开,随后走势有所分化。截至发稿,道琼斯指数下跌0.37%;纳斯达克指数上涨0.46%...
09-22 22:52
U.S. stocks were higher, with the Nasdaq Composite gaining over 1% on Monday. Shares of On Holding AG (NYSE:ONON) rose sharply after the company affirmed its FY26 sales guidance above estimates and issued third-quarter sales guidance above estimates. On Holding also announced a $1 billion stock buyb...
09-22 22:25
Viking Therapeutics周二盘前一度飙升近50%,此前这家生物科技公司宣布,其实验性肥胖症药物VK2735帮助患者在用药频率从每周一次降至每两周一次的情况下,仍维持了大部分减重成果。
09-22 21:58
Viking Therapeutics shares are trading higher after the company announced top-line results from the maintenance study of VK2735.
09-22 19:57
VICR: 13% | Vicor shares are trading higher after the company raised its Q3 revenue guidance. VKTX: 38% | Viking Therapeutics Announces Top-line Results From Maintenance Study Of VK2735, A Dual Agonist Of GLP-1 And Glucose-Dependent Insulinotropic Polypeptide Receptors; 22% Placebo-Adjusted Weight...
09-22 19:16
Baron Global Opportunity Fund (Institutional Shares) outperformed with a return of 26.7% in Q2 2026, compared with 14.9% for the MSCI ACWI Index and 19.8% for the MSCI ACWI Growth Index. The fund init...
09-17 21:59